



































spectrometry	method	 has	 been	 developed	 and	 subsequently	 validated	 for	 the	 simultaneous
determination	 of	 Moexipril	 (MOX),	 and	 its	 active	 metabolite	 Moexiprilat	 (MOXT)	 in	 spiked
human	 plasma,	 using	 Benazepril	 (BENZ)	 as	 an	 internal	 standard	 (IS).	 Various	modes	were
tried	and	the	Multiple	Reaction	Monitoring	(MRM)	mode	was	found	the	most	suitable	one.	The


















phenylpropyl]amino]‐1‐oxopropyl]‐1,	 2,	 3,	 4‐tetrahydro‐6,	 7‐
dimethoxy‐3‐isoquinolinecarboxylic	acid	[1]	is	an	antihyperten‐
sive	drug,	which	belongs	to	the	group	of	angiotensin	convertase	
inhibitors.	 Moexipril	 hydrochloride	 is	 a	 long‐acting	 non‐
sulfhydryl	 angiotensin‐converting	 enzyme	 (ACE)	 inhibitor,	
developed	 for	 the	 treatment	 of	 hypertension	 and	 congestive	
heart	 failure.	 Moexipril	 is	 a	 pro‐drug	 of	 moexiprilat,	 which	
inhibits	ACE	in	humans	and	animals.	In	biological	systems	it	is	
rapidly	 de‐esterified	 by	 esterases,	 resulting	 in	 its	 active	
metabolite	moexiprilat	[2,3].	
It	 is	 reported	 that	 MOX	 was	 identified	 by	 HPLC	 [4‐6],	
spectrophotometry	 [7,8],	 gas	 chromatography	 mass	 spectro‐
metry	 [9],	 and	 liquid	 chromatography	 tandem	 mass	 spectro‐










This	 manuscript	 presents	 for	 the	 first	 time	 the	 develop‐









MOX	 and	 BENZ	 were	 kindly	 supplied	 from	 National	
Organization	 for	 Drug	 Control	 and	 Research	 (NODCAR,	 Cairo,	




















HPLC‐grade	 acetonitrile	 (Sigma‐Aldrich),	 and	 ultrapure	
water	 prepared	 by	 a	 Millipore	 Milli‐Q	 purification	 system	
(Millipore	Corp.	Bedford,	MA,	USA)	were	used	as	mobile	phase	
of	 the	 HPLC‐MS‐MS.	 Other	 reagents	 were	 of	 analytical‐grade.	






Analysis	 was	 performed	 on	 a	 chromatographic	 system	
Shimadzu	LC‐20	AT	Series	HPLC	system	(Japan)	equipped	with	
LC‐20	 AT	 HPLC	 pump,	 Shimadzu	 series	 DGU‐20A5	 Degasser	
and	 a	 Shimadzu	 SIL‐20A	 auto	 sampler.	 A	 chromatographic	
separation	was	achieved	by	a	Sunfire	C18	column	(50×4.6	mm,	
5	 µm,	 Waters,	 USA)	 and	 a	 mixture	 of	 0.1%	 formic	 acid:	
acetonitrile	(30:70,	v:v)	as	a	mobile	phase.	The	isocratic	mobile	
phase,	 was	 filtered	 through	 a	 0.45	 µm	 membrane	 filter	
(Millipore,	USA),	then	sent	to	sonicator	for	5	min.	The	flow	rate	
used	was	0.8	mL/min.	







The	 compound	 parameters,	 collision	 exit	 potential	 (CXP),	
collision	 energy	 (CE),	 and	 declustering	 potential	 (DP)	 for	 the	
analytes	 and	 IS	 were	 set	 at	 12,	 31,	 and	 56	 V,	 respectively.	
Simultaneous	quantitative	determination	of	MOX,	MOXT,	and	IS	
was	 done	 by	 monitoring	 the	 parent/daughter	 ions	 at	 m/z	












the	 standard	 working	 solutions	 were	 used	 for	 spiking	 blank	
human	 plasma	 to	 prepare	 calibration	 standards	 and	 quality	
control	 samples.	 Six	 different	 concentrations	 of	MOX	 (0.5‐100	
ng/mL)	and	MOXT	(5‐200	ng/mL)	were	used	as	the	calibration	






A	 simple	 protein	 precipitation	 was	 done	 for	 extracting	




The	 Centrifugation	 was	 done	 at	 10,000	 rpm	 for	 10	 min.	 The	
clear	 supernatant	 was	 transferred	 to	 a	 dry	 test	 tube	 and	
evaporated	to	dryness	under	a	gentle	stream	of	nitrogen	gas	at	
40	 °C,	 and	 then	 the	 residue	was	 reconstituted	with	100	µL	of	







MOX	 was	 subjected	 to	 basic	 degradation.	 Standard	 MOX	









Aliquot	 volumes	 from	 the	 standard	 working	 solutions	 of	
MOX	 and	 MOXT	 were	 accurately	 transferred	 to	 10	 mL	 volu‐
metric	flasks	to	which	500	µL	of	IS	was	added	to	provide	final	
concentrations	 of	 0.5‐100	 ng/mL	 for	 MOX,	 and	 5‐200	 ng/mL	
for	 MOXT.	 The	 volume	 was	 completed	 to	 the	 volume	 by	 the	





Aliquot	 volumes	 from	 the	 standard	 working	 solutions	 of	
MOX	and	MOXT	were	added	on	500	µL	human	plasma,	then	25	
µL	 IS	was	 added	 on	 each	 concentration.	 Then,	 3	mL	 of	 aceto‐























It	 is	 the	 effect	 of	 the	 matrix	 which	 contains	 the	 analysed	
sample	 on	 the	 sample	 determination.	 To	 test	 for	 the	 effect	 of	




IS	 in	 triplicates.	 Then	 the	 samples	 were	 sent	 for	 analysis	 to	
obtain	the	peak	areas.	The	peak	areas	obtained	were	compared	
with	 those	 obtained	 from	 standard	 solutions,	 where	 matrix	





Calculation	 of	 the	 recovery	 %	 is	 done	 to	 test	 for	 the	
extraction	 efficiency	 of	 the	method.	 The	 extraction	 procedure	
was	done	 as	mentioned	 above	 for	 the	 spiked	plasma	 samples	
and	 the	 peak	 areas	 were	 calculated.	 Then	 the	 peak	 areas	 of	
samples	 spiked	 after	 the	 extraction	 step	 was	 calculated.	 The	






MOX	 (0.5‐100	 ng/mL)	 and	 MOXT	 (5‐200	 ng/mL).	 Each	
concentration	was	injected	three	times.	The	relative	peak	area	






Three	 different	 QC	 levels	 of	 each	 analyte	 were	 analysed	
three	times	 intra‐daily	using	the	proposed	methods	under	the	
same	 experimental	 conditions	 to	 estimate	 precision	 and	
accuracy.	 The	 previous	 procedures	 were	 repeated	 inter‐daily	
on	 three	 different	 days	 for	 the	 analysis	 of	 the	 three	 chosen	
concentrations	 to	 calculate	 the	 inter‐assay	 precision.	 The	
relative	 standard	 deviations	 were	 calculated.	 The	 criteria	 for	
acceptability	 of	 data	 were	 accuracy	 within	 ±15%	 from	 the	
nominal	 values	 and	 a	 precision	 of	 within	 ±15%	 relative	







To	 test	 for	 the	 short	 term	 stability	 of	 the	 analytes,	 three	
quality	 control	 levels	 were	 left	 for	 8	 hours	 on	 bench	 top	 at	





Three	 freeze	 and	 thaw	 cycles	were	 applied	 to	 test	 for	 the	
analytes’	stability.	The	general	procedure	mentioned	above	was	





The	 stability	 of	 MOX,	 MOXT,	 and	 I.S	 stock	 solutions	 was	
performed	 by	 comparison	 of	 results	 from	 a	 solution	 kept	 for	
about	 60	 days	 at	 4	 °C	 and	 from	 a	 solution	 that	 was	 extem‐
poraneously	 prepared.	 For	 this	 purpose,	 three	 replicates	 of	
each	 analyte	 were	 prepared	 from	 each	 stock	 solution	 and	
injected	in	the	LC‐MS/MS	system.	The	same	test	was	performed	










Both	 positive	 and	 negative	 ion	 modes	 were	 tried	 for	 the	
simultaneous	 determination	 of	 the	mixture	 by	using	 only	 one	
internal	 standard.	The	Positive	 ion	mode	was	 found	 to	be	 the	
most	 suitable	 for	 the	 LC‐tandem	 mass	 multiple	 reaction	
monitoring	(MRM)	analyses.	Parent	 ion	of	each	analyte	and	 IS	
[M+H]+	 in	 the	 first	 MS	 was	 used	 to	 give	 the	 most	 intense	
product	ion	peak	in	MS3	where	it	was	used	for	the	quantitative	
measurement.	
The	 parent	 ion	 of	 the	 protonated	 MOX	 and	 MOXT	 (m/z,	







Different	 ratios	 of	 acetonitrile	 and	 buffer	 were	 tested	 for	
optimum	 resolution	 in	 a	 reasonable	 run	 time	 and	 acceptable	
peak	 shape.	 The	 most	 satisfactory	 mobile	 phase	 ratio	 was	
found	to	be	0.1%	formic	acid	and	acetonitrile	(30:70,	v:v).	Two	
types	of	stationary	phases	C8	and	C18	were	investigated	for	the	
optimum	 resolution	 of	 the	 analytes	 peaks,	 however	 the	more	





Simple	 protein	 precipitation	 was	 used	 to	 obtain	 samples	
free	 from	 endogenous	 interferents,	 which	 are	 essential	 for	
increasing	 recovery	 and	 minimizing	 matrix	 effects	 in	 LC‐
tandem	 mass	 spectrometry.	 Different	 precipitating	 solvents,	
like	 methanol,	 and	 acetonitrile	 were	 tried	 and	 tested	 for	
removing	 interferents	 and	 obtaining	 clean	 plasma	 samples	
leading	to	acceptable	matrix	effect	and	recoveries.	Acetonitrile	





Internal	 standard	 (IS)	 is	 used	 to	 compensate	 for	 the	









To	 test	 for	 the	 method	 selectivity,	 blank	 plasma	 samples	
from	 six	 different	 sources	 were	 analyzed	 to	 be	 sure	 that	 the	
endogenous	 plasma	 constituents	 show	 no	 interference	 at	 the	


















x±SD RSD	% x±SD 		 RSD	%
Moexipril	 15	 84.6±3.87 4.57 99.7±2.45 	 2.46
50	 83.7±5.41 6.46 98.3±1.48 	 1.50
180	 84.6±5.23 6.18 98.7±1.62 	 1.64
Moexiprilat	 3	 86.5±4.84	 	 5.60	 	 98.9±2.16	 	 2.18	
30	 85.1±8.64	 	 10.15	 	 99.5±3.12	 	 3.14	
100	 85.5±2.47 2.89 99.4±1.57 	 1.58








The	 analyte	 response	 at	 the	 LLOQ	 should	 be	 at	 least	 five	
times	 the	 response	 of	 blank	 baseline.	 To	 test	 for	 LLOQ	 of	 the	
proposed	 method,	 three	 replicates	 of	 the	 spiked	 plasma	
samples	were	analyzed	at	concentrations	of	0.5	and	5.0	ng/mL	






Different	 precipitating	 solvents	were	 tried	 to	 obtain	 clean	









The	 two	 analytes	 showed	 linear	 response	 where	 the	
correlation	 coefficients	 (r2)	were	 all	 >	 0.998.	 The	 equation	 of	
each	calibration	curve	was:	y	=	0.0068X	‐	0.0072	(r2	=	0.9981,	n	




















x±SD	 Accuracy	% RSD	% x±SD Accuracy	%	 RSD	%
Moexipril	 15	 14.56±1.41	 97.1 9.68 14.78±2.14 98.5	 14.48
50	 51.23±0.57	 102.5 1.11 48.89±1.87 97.8	 3.82
100	 98.63±1.37	 98.6 1.39 98.32±0.25 98.3	 0.25
Moexiprilat	 5	 4.870±0.41	 97.4 8.42 4.840±0.23 96.8	 4.75
30	 29.47±1.25	 98.2	 4.24	 	 31.26±0.54	 104.2	 1.73	




Analyte	 C	(ng/mL)	 		 Bench	top	(8	h) Three	freeze‐thaw	
Moexipril	 15	 x±SD	 14.98±0.43	 14.21±3.14	
	 Accuracy	% 99.87 94.73	
50	 x±SD 50.56±0.48 48.87±2.87	
	 Accuracy	% 101.12 97.74	
100	 x±SD 100.69±1.24 101.24±3.04	
	 Accuracy	% 100.69 101.24	
Moexiprilat	 5	 x±SD	 5.08±1.12	 5.19±2.47	
	 Accuracy	% 101.60 103.80	
30	 x±SD 30.87±0.76 31.65±2.41	
	 Accuracy	% 102.90 105.50	
100	 x±SD 99.78±1.42 98.78±0.58	















the	 spiked	 human	 plasma	 for	 8	 hours	 on	 bench‐top.	 The	












The	 stability	 of	 the	 analytes	 in	 human	 plasma	 was	
investigated	 under	 the	 conditions	 recommended	 by	 the	 FDA	
[12].	 So,	 freeze‐thaw	stability	was	 assessed	with	 three	 sets	 of	






Method	 Drug	 Mean	 S.D.	 RSD%	 N	 Variance	 Student's	t	test	(2.23)	a	 F	test	(5.05)	a	
LC/MS	 MOX	 99.32	 2.77 2.788 6 7.672 0.258 1.681


















performed	 by	 comparison	 of	 results	 from	 a	 solution	 kept	 for	
about	60	days	at	4	°C	and	from	a	solution	that	was	extempora‐
neously	 prepared.	 For	 this	 purpose,	 three	 replicates	 of	 each	
analyte	were	prepared	from	each	stock	solution	and	injected	in	
the	LC‐MS/MS	system.	The	same	test	was	performed	with	 the	






Results	 obtained	 by	 the	 proposed	 method	 for	 the	 deter‐
mination	 of	 pure	 samples	 of	 MOX	 and	MOXT	 are	 statistically	
compared	 to	 those	 obtained	 by	 the	 reported	 methods4.	 The	
calculated	 t	 and	 F	 values	 were	 found	 to	 be	 less	 than	 their	




In	 the	 present	 study,	 both	 MOX	 and	 its	 active	 metabolite	
MOXT	 were	 determined	 in	 spiked	 human	 plasma	 by	 LC‐
Tandem	mass	spectrometry	method	using	one	IS.	The	method	
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